A positive troponin can hijack a carbon monoxide question: you see the number and jump to acute coronary syndrome, while persistent confusion is still signaling possible neurologic involvement. When both findings appear despite oxygen, the board task is to prioritize urgent hyperbaric oxygen consultation and assess transfer feasibility—while continuing 100% oxygen and evaluating the heart in parallel. It is not to diagnose an infarction from one biomarker or declare that chamber treatment is automatic.
Read the two organ signals, not just the number
Carbon monoxide can injure the brain and heart through impaired oxygen delivery and other cellular effects. In a stem that describes ongoing confusion and an elevated troponin, treat them as separate signs of possible neurologic and cardiac involvement. Together, they make prompt escalation for specialist discussion more compelling than either clue considered as an isolated number.
Keep the troponin in its lane. A result above the assay- and sex-appropriate 99th-percentile upper reference limit indicates myocardial injury; a rise or fall with at least one value above that threshold supports acute myocardial injury. Neither finding alone proves myocardial infarction. MI also requires evidence of acute ischemia. Ask whether there are ischemic symptoms, ECG changes, imaging evidence, or other clinical findings that support an acute coronary diagnosis.
An older cohort study of moderate-to-severe CO poisoning used a troponin I value of at least 0.7 ng/mL as one part of a study-specific definition of myocardial injury. That was not a universal MI or hyperbaric-treatment threshold. Assays, units, and reference limits differ.
| Stem clue | What it supports | What it does not establish alone |
|---|---|---|
| Confusion that persists during oxygen treatment | Possible ongoing neurologic involvement; reassess the neurologic state and trajectory | That CO is the only cause, especially if baseline cognition or other causes are unknown |
| Troponin reported as elevated | Possible myocardial injury and a reason to assess cardiac involvement | Acute MI, its mechanism, or a universal hyperbaric-treatment cutoff |
| Both findings together | A higher-risk pattern that warrants urgent specialist discussion about hyperbaric treatment | That every patient must receive chamber treatment regardless of transport risk or availability |
A short stem may not give the patient’s baseline cognition, cardiac history, chest symptoms, ECG, exposure timeline, or time away from the source. Do not invent those details. In a real assessment, clarify what is new, examine for other causes of confusion, and establish whether the cardiac findings fit ischemia. On an exam, answer the decision supported by the information given, then name the important parallel assessments.
Make the next step an action, not a label
A board-ready answer is: continue 100% oxygen and promptly contact a hyperbaric center and poison-control or toxicology resource to discuss treatment and transfer. Stabilization and monitored care continue while that discussion happens. The immediate move is an urgent expert assessment—not an assumption that the emergency department should initiate chamber treatment without considering the patient’s condition, distance, and transport risks.
Do not make a single carboxyhemoglobin value or a fixed time on oxygen the gate for consultation. COHb levels can be hard to interpret after time has passed or oxygen has been given, and they do not reliably track clinical severity. In this pattern, the ongoing neurologic finding and evidence of cardiac involvement matter even if the stem does not supply a dramatic COHb number.
That does not mean hyperbaric oxygen is mandatory. Guidance recognizes uncertainty about whether it improves long-term outcomes for every patient; the potential benefit is weighed against symptom severity, chamber availability, travel time, and the risks of transfer. For an exam, distinguish consult now about suitability from the patient must receive hyperbaric oxygen. The first is a defensible next action for this high-risk presentation; the second overstates certainty.
Keep the cardiac track moving in parallel
The hyperbaric call should not replace cardiac evaluation. Review or obtain an ECG, assess for chest discomfort or hemodynamic instability, monitor for dysrhythmia, and interpret repeat troponins using the local assay and pathway when indicated. If the history, ECG, or clinical course supports acute ischemia, manage that concern through the appropriate ACS pathway alongside CO-directed care.
The common reasoning error is to treat the choices as mutually exclusive: either hyperbaric referral or cardiac workup. The better answer separates the immediate disposition question from the diagnostic question. Confusion plus myocardial injury supports urgent discussion about hyperbaric care; the troponin alone does not tell you whether the patient has a coronary occlusion or needs a particular ACS treatment.
A four-minute retrieval exercise
Close your notes and write a two-sentence answer to a brief CO-poisoning stem with persistent confusion and an elevated troponin after oxygen. Sentence one should name the immediate action: continue 100% oxygen and urgently discuss hyperbaric suitability and transfer with the relevant specialists. Sentence two should keep the cardiac assessment active without calling the biomarker an MI diagnosis.
Then change one fact at a time. If the patient has returned to their usual mental state and the cardiac assessment is reassuring, explain why the hyperbaric decision is less compelling and still individualized. If new ischemic ECG changes or instability appear, state how cardiac escalation joins—not replaces—the CO-poisoning plan. Finally, check your answer against three errors: did you rely on a COHb cutoff, call one troponin value an infarction, or present hyperbaric treatment as guaranteed?
Practical takeaways
- Persistent confusion plus an elevated troponin is a high-risk CO pattern: continue 100% oxygen and seek urgent hyperbaric consultation and transfer assessment.
- Treat an elevated troponin as evidence of possible myocardial injury, not proof of MI or a universal chamber-treatment threshold.
- Keep ECG-based and clinical cardiac assessment moving in parallel; hyperbaric consultation does not settle the ACS question.
- Say consult about suitability, not HBO is mandatory. Severity, availability, and transfer risk matter.
